ATE225805T1 - Hundecoronavirus s gen und verwendung davon - Google Patents

Hundecoronavirus s gen und verwendung davon

Info

Publication number
ATE225805T1
ATE225805T1 AT93911346T AT93911346T ATE225805T1 AT E225805 T1 ATE225805 T1 AT E225805T1 AT 93911346 T AT93911346 T AT 93911346T AT 93911346 T AT93911346 T AT 93911346T AT E225805 T1 ATE225805 T1 AT E225805T1
Authority
AT
Austria
Prior art keywords
gene
ecoronavirus
dog
ccv
spike gene
Prior art date
Application number
AT93911346T
Other languages
English (en)
Inventor
Timothy J Miller
Sharon Klepfer
Albert Paul Reed
Elaine V Jones
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE225805T1 publication Critical patent/ATE225805T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93911346T 1992-05-08 1993-05-07 Hundecoronavirus s gen und verwendung davon ATE225805T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88019492A 1992-05-08 1992-05-08
PCT/US1993/004692 WO1993023423A1 (en) 1992-05-08 1993-05-07 Canine coronavirus s gene and uses therefor

Publications (1)

Publication Number Publication Date
ATE225805T1 true ATE225805T1 (de) 2002-10-15

Family

ID=25375695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911346T ATE225805T1 (de) 1992-05-08 1993-05-07 Hundecoronavirus s gen und verwendung davon

Country Status (10)

Country Link
EP (1) EP0640098B1 (de)
JP (1) JP3245169B2 (de)
AT (1) ATE225805T1 (de)
AU (1) AU670092B2 (de)
CA (1) CA2135200C (de)
DE (1) DE69332375T2 (de)
DK (1) DK0640098T3 (de)
ES (1) ES2182827T3 (de)
PT (1) PT640098E (de)
WO (1) WO1993023423A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07508176A (ja) * 1992-05-08 1995-09-14 ファイザー・インコーポレイテッド 普遍コロナウイルスワクチン
GB2282601B (en) * 1993-09-16 1998-04-15 Solvay Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
FR2828405B1 (fr) 2001-08-09 2005-06-24 Virbac Sa Vaccin anti-coronavirus
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
CN113583096B (zh) * 2020-05-01 2023-06-30 清华大学 SARS-CoV-2 Spike蛋白受体结合域二聚体及其应用
CN112079906B (zh) * 2020-07-15 2022-11-04 张影 一种新型冠状病毒刺突蛋白、相关生物材料及其应用、检测试纸和检测试剂盒
CN113945714B (zh) * 2020-07-16 2023-01-31 南京蓬勃生物科技有限公司 新型冠状病毒中和抗体类药物中和能力的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63123385A (ja) * 1986-09-05 1988-05-27 デュファル・インテルナチオナル・レセールフ・ベー・ヴェー 新規抗原的活性蛋白質およびぺプチド、並びにネコ科感染性腹膜炎ウイルスワクチン
HUT45559A (en) * 1987-01-16 1988-07-28 Duphar Int Res Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
ES2213743T3 (es) * 1991-04-25 2004-09-01 Akzo Nobel N.V. Vacuna de subunidad de coronavirus canino.
EP0524672A1 (de) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV-Impfstoff
JPH07508176A (ja) * 1992-05-08 1995-09-14 ファイザー・インコーポレイテッド 普遍コロナウイルスワクチン

Also Published As

Publication number Publication date
CA2135200C (en) 2001-03-27
DE69332375T2 (de) 2003-02-13
JPH07508421A (ja) 1995-09-21
DK0640098T3 (da) 2002-10-28
AU670092B2 (en) 1996-07-04
EP0640098A4 (de) 1997-01-02
EP0640098B1 (de) 2002-10-09
AU4251593A (en) 1993-12-13
JP3245169B2 (ja) 2002-01-07
DE69332375D1 (de) 2002-11-14
PT640098E (pt) 2003-01-31
WO1993023423A1 (en) 1993-11-25
CA2135200A1 (en) 1993-11-25
EP0640098A1 (de) 1995-03-01
ES2182827T3 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
ATE244304T1 (de) Verfahren zur veränderung des essverhaltens, dafür verwendbare verbindungen und dna, die einen hypothalamischen atypischen neuropeptid y/peptid yy rezeptor (y5) kodiert
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
IL136690A0 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
PE14199A1 (es) Agonistas de 5-ht1f
MY131388A (en) Inhibitors of hiv protease useful for the treatment of aids.
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
IL138402A0 (en) Heterocyclically substituted amides used as calpain inhibitors
DE50212935D1 (de) Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen
EP1001782A4 (de) 5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
NO973685L (no) Multi-tumor avvikende vekstgener
IL162917A0 (en) A lysin from bacteriophage and pharmaceutical compositions containing the same
ATE226947T1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung
ATE304052T1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ATE225805T1 (de) Hundecoronavirus s gen und verwendung davon
EP0387802A3 (de) 5-Substituierte 1,4-Dihydro-4-oxonaphthyridin-3-carbonsäure als antibakterielles Mittel
DE69328549D1 (de) Für einen humanen serotoninrezeptor (5-ht4b) kodierende dns und ihre verwendung
DE69735039D1 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
ID25478A (id) Agonis 5-ht1f
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
ATE179990T1 (de) Cyclische pentapeptide mit beta-turn und gamma- turn
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0640098

Country of ref document: EP

REN Ceased due to non-payment of the annual fee